Track topics on Twitter Track topics that are important to you
Bayer and Arvinas said they have finalized terms for a joint venture that will apply Arvinas’ platform for engineering proteolysis-targeting chimeras (PROTAC®) protein degraders in order to develop sustainable products that control diseases, pests, and weeds by addressing resistance mechanisms in plants.NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...